| Guidelines for diagnosis, treatment, and prevention ofclostridium difficileInfections CM Surawicz, LJ Brandt, DG Binion, AN Ananthakrishnan, SR Curry, ... Official journal of the American College of Gastroenterology| ACG 108 (4 …, 2013 | 2222 | 2013 |
| Nosocomial acquisition of Clostridium difficile infection LV McFarland, ME Mulligan, RYY Kwok, WE Stamm New England journal of medicine 320 (4), 204-210, 1989 | 1880 | 1989 |
| Meta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the treatment of Clostridium difficile disease LV McFarland Official journal of the American College of Gastroenterology| ACG 101 (4 …, 2006 | 1329 | 2006 |
| A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease LV McFarland, CM Surawicz, RN Greenberg, R Fekety, GW Elmer, ... Jama 271 (24), 1913-1918, 1994 | 1212 | 1994 |
| Breaking The Cycle: Treatment Strategies for 163 Cases of RecurrentClostridium DifficileDisease LV McFarland, GW Elmer, CM Surawicz Official journal of the American College of Gastroenterology| ACG 97 (7 …, 2002 | 882 | 2002 |
| Prevention of antibiotic-associated diarrhea by Saccharomyces boulardii: a prospective study CM Surawicz, GW Elmer, P Speelman, LV McFarland, J Chinn, ... Gastroenterology 96 (4), 981-988, 1989 | 828 | 1989 |
| Systematic review and meta-analysis of Saccharomyces boulardii in adult patients LV McFarland World journal of gastroenterology: WJG 16 (18), 2202, 2010 | 760 | 2010 |
| The Search for a Better Treatment for Recurrent Clostridium difficile Disease: Use of High-Dose Vancomycin Combined with Saccharomyces boulardii CM Surawicz, LV McFarland, RN Greenberg, M Rubin, R Fekety, ... Clinical infectious diseases 31 (4), 1012-1017, 2000 | 742 | 2000 |
| Meta-analysis of probiotics for the prevention of traveler's diarrhea LV McFarland Travel medicine and infectious disease 5 (2), 97-105, 2007 | 680 | 2007 |
| Biotherapeutic agents: a neglected modality for the treatment and prevention of selected intestinal and vaginal infections GW Elmer, CM Surawicz, LV McFarland Jama 275 (11), 870-876, 1996 | 654 | 1996 |
| Risk Factors for Clostridium difficile Carriage and C. difficile-Associated Diarrhea in a Cohort of Hospitalized Patients LV McFarland, CM Surawicz, WE Stamm Journal of infectious diseases 162 (3), 678-684, 1990 | 592 | 1990 |
| Epidemiology, risk factors and treatments for antibiotic-associated diarrhea LV McFarland Digestive Diseases 16 (5), 292-307, 1999 | 561 | 1999 |
| Prevention of b-lactam-associated diarrhea by Saccharomyces boulardii compared with placebo LV McFarland, CM Surawicz, RN Greenberg, GW Elmer, KA Moyer, ... American Journal of Gastroenterology 90 (3), 439-448, 1995 | 525 | 1995 |
| Meta-analysis of probiotics for the treatment of irritable bowel syndrome LV McFarland, S Dublin World journal of gastroenterology: WJG 14 (17), 2650, 2008 | 515 | 2008 |
| Recurrent Clostridium difficile Diarrhea: Characteristics of and Risk Factors for Patients Enrolled in a Prospective, Randomized, Double-Blinded Trial R Fekety, LV McFarland, CM Surawicz, RN Greenberg, GW Elmer, ... Clinical Infectious Diseases 24 (3), 324-333, 1997 | 469 | 1997 |
| Recurrent Clostridium difficile disease: epidemiology and clinical characteristics LV McFarland, CM Surawicz, M Rubin, R Fekety, GW Elmer, ... Infection Control & Hospital Epidemiology 20 (1), 43-50, 1999 | 464 | 1999 |
| Antibiotic-associated diarrhea: epidemiology, trends and treatment LV McFarland Future Medicine Ltd 3 (5), 563-578, 2008 | 455 | 2008 |
| Strain-specificity and disease-specificity of probiotic efficacy: a systematic review and meta-analysis LV McFarland, CT Evans, EJC Goldstein Frontiers in medicine 5, 124, 2018 | 433 | 2018 |
| Incidence and risk factors of oral antibiotic-associated diarrhea in an outpatient pediatric population D Turck, JP Bernet, J Marx, H Kempf, P Giard, O Walbaum, A Lacombe, ... Journal of pediatric gastroenterology and nutrition 37 (1), 22-26, 2003 | 356 | 2003 |
| Saccharomyces boulardii'. A review of an innovative biotherapeutic agent LV McFarland, P Bernasconi Microbial ecology in health and disease 6 (4), 157-171, 1993 | 319 | 1993 |
